WallStreetZenWallStreetZen

NASDAQ: RVMD
Revolution Medicines Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for RVMD

Based on 6 analysts offering 12 month price targets for Revolution Medicines Inc

Min Forecast
$57.00+49.92%
Avg Forecast
$69.17+81.92%
Max Forecast
$80.00+110.42%

Should I buy or sell RVMD stock?

Based on 6 analysts offering ratings for Revolution Medicines Inc.

Strong Buy
Strong Buy
2 analysts 33.33%
Buy
4 analysts 66.67%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although RVMD's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates RVMD as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their RVMD stock forecasts and price targets.

RVMD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-06-25
lockedlocked$00.00+00.00%2025-06-24
lockedlocked$00.00+00.00%2025-05-14
lockedlocked$00.00+00.00%2025-05-08
lockedlocked$00.00+00.00%2025-04-28
Stifel Nicolaus
Bottom 6%
6
Strong BuyMaintains$64.00+68.33%2025-04-01

1 of 1

Forecast return on equity

Is RVMD forecast to generate an efficient return?

Company
-11.47%
Industry
167.47%
Market
90.43%
RVMD's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is RVMD forecast to generate an efficient return on assets?

Company
-10.08%
Industry
44.43%
RVMD is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

RVMD earnings per share forecast

What is RVMD's earnings per share in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
-$4.33
Avg 2 year Forecast
-$4.88
Avg 3 year Forecast
-$3.72

RVMD revenue forecast

What is RVMD's revenue in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$144.0M
Avg 2 year Forecast
$103.5M
Avg 3 year Forecast
$316.7M

RVMD vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
RVMD$38.02$69.17+81.92%Strong Buy
HALO$57.15$66.40+16.19%Buy
NNNN$49.26N/AN/A
MDGL$315.46$442.50+40.27%Strong Buy
LEGN$38.96$70.00+79.67%Strong Buy
View Top Biotech Stocks

Revolution Medicines Stock Forecast FAQ

Is Revolution Medicines Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: RVMD) stock is to Strong Buy RVMD stock.

Out of 6 analysts, 2 (33.33%) are recommending RVMD as a Strong Buy, 4 (66.67%) are recommending RVMD as a Buy, 0 (0%) are recommending RVMD as a Hold, 0 (0%) are recommending RVMD as a Sell, and 0 (0%) are recommending RVMD as a Strong Sell.

If you're new to stock investing, here's how to buy Revolution Medicines stock.

What is RVMD's earnings growth forecast for 2025-2027?

(NASDAQ: RVMD) Revolution Medicines's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 9.68%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.82%.

Revolution Medicines's earnings in 2025 is -$697,506,000.On average, 8 Wall Street analysts forecast RVMD's earnings for 2025 to be -$807,246,282, with the lowest RVMD earnings forecast at -$892,221,536, and the highest RVMD earnings forecast at -$620,270,922. On average, 8 Wall Street analysts forecast RVMD's earnings for 2026 to be -$908,743,467, with the lowest RVMD earnings forecast at -$976,041,931, and the highest RVMD earnings forecast at -$756,246,229.

In 2027, RVMD is forecast to generate -$693,380,933 in earnings, with the lowest earnings forecast at -$1,091,527,808 and the highest earnings forecast at -$135,975,307.

What is RVMD's revenue growth forecast for 2025-2027?

(NASDAQ: RVMD) Revolution Medicines's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 57.08%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.39%.

Revolution Medicines's revenue in 2025 is $0.On average, 4 Wall Street analysts forecast RVMD's revenue for 2025 to be $26,822,526,336, with the lowest RVMD revenue forecast at $2,514,611,844, and the highest RVMD revenue forecast at $46,566,886,000. On average, 3 Wall Street analysts forecast RVMD's revenue for 2026 to be $19,277,945,734, with the lowest RVMD revenue forecast at $7,728,240,401, and the highest RVMD revenue forecast at $26,822,526,336.

In 2027, RVMD is forecast to generate $58,981,617,808 in revenue, with the lowest revenue forecast at $8,626,049,963 and the highest revenue forecast at $112,915,385,173.

What is RVMD's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: RVMD) forecast ROA is -10.08%, which is lower than the forecast US Biotechnology industry average of 44.43%.

What is RVMD's Price Target?

According to 6 Wall Street analysts that have issued a 1 year RVMD price target, the average RVMD price target is $69.17, with the highest RVMD stock price forecast at $80.00 and the lowest RVMD stock price forecast at $57.00.

On average, Wall Street analysts predict that Revolution Medicines's share price could reach $69.17 by Jun 25, 2026. The average Revolution Medicines stock price prediction forecasts a potential upside of 81.92% from the current RVMD share price of $38.02.

What is RVMD's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: RVMD) Revolution Medicines's current Earnings Per Share (EPS) is -$4.01. On average, analysts forecast that RVMD's EPS will be -$4.33 for 2025, with the lowest EPS forecast at -$4.79, and the highest EPS forecast at -$3.33. On average, analysts forecast that RVMD's EPS will be -$4.88 for 2026, with the lowest EPS forecast at -$5.24, and the highest EPS forecast at -$4.06. In 2027, RVMD's EPS is forecast to hit -$3.72 (min: -$5.86, max: -$0.73).

What is RVMD's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: RVMD) forecast ROE is -11.47%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.